Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small integral membrane protein 5 (SMIM5) is a protein encoded by the SMIM5 gene (previously known as C17orf109)[1]. This protein is predicted to be a small membrane protein, likely localized to cellular membranes, but its precise function in humans remains undefined[1][3]. There is currently no experimental evidence supporting specific molecular functions or biological processes for SMIM5, and it is not classified as a receptor, enzyme, transporter, or other established drug target class[1][3][5]. Expression data indicate transcription in various tissues, but functional roles and disease associations have not been established[6][7]. As of now, SMIM5 is not recognized as a therapeutic target, nor are there drugs or established disease links associated with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small integral membrane protein 5 (SMIM5).